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BACKGROUND: It is widely accepted that periconceptional supplementation with folic acid can prevent a signifi-
cant proportion of neural tube defects (NTDs). The present study evaluated how folic acid knowledge and pericon-
ceptional use for NTD prevention varies by ethnicity in the United Kingdom (U.K.).METHODS: A literature search
was conducted to identify studies that included assessment of folic acid knowledge or use in U.K. women of differ-
ent ethnicities. Only research and referenced sources published after 1991, the year of the landmark Medical
Research Council’s Vitamin Study, were included. A meta-analysis was performed of studies that assessed precon-
ceptional folic acid use in Caucasians and non-Caucasians. RESULTS: Five studies met the inclusion criteria for
assessment of knowledge and/or use of folic acid supplements in U.K. women including non-Caucasians. The
available evidence indicates that South Asians specifically have less knowledge and lower periconceptional use of
folic acid than Caucasians; one study found that West Indian and African women also had lower folic acid uptake.
A synthesis of results from three of the studies, in a meta-analysis, shows that Caucasians are almost three times
more likely to take folic acid before conception than non-Caucasians. CONCLUSION: From the limited evidence
available, U.K. women of non-Caucasian ethnicity appear to have less knowledge and a lower uptake of
folic acid supplementation than Caucasians during the periconceptional period. Implementing targeted,
innovative education campaigns together with a mandatory fortification policy, including the fortification of
ethnic minority foods, will be required for maximum prevention of folic acid–preventable NTDs across dif-
ferent ethnic groups. Birth Defects Research (Part A) 97:444–451, 2013. VC 2014 The Authors Birth Defects
Research Part A: Clinical and Molecular Teratology Published by Wiley Periodicals, Inc.
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INTRODUCTION
Neural tube defects (NTDs) are congenital abnormalities
caused by failed closure of the embryonic neural tube.
Closure is normally complete by day 28 of pregnancy,
before many women know they are pregnant. NTDs affect
0.5–2 in every 1000 pregnancies worldwide (Greene at al.,
2009), with a prevalence in the United Kingdom (U.K.)
estimated to be 1 per 1000 births (EUROCAT, 2009).
The 1991 international Medical Research Council dou-
ble blind randomized controlled trial was the first to
unambiguously show a link between folic acid
supplementation and NTD reduction. There was a 72%
reduction in NTD recurrence in women taking folic acid
supplements (MRC Vitamin Study Research Group,
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1991). It was argued by the authors that although the
trial assessed NTD reduction in those with a previous
NTD-affected pregnancy, there was no reason to expect
that folic acid would not have the same effect on first
occurrence NTDs (MRC Vitamin Study Research Group,
1991). Indeed, a subsequent Hungarian randomized clini-
cal trial confirmed that folic acid also has a protective
effect for first occurrence NTDs (Czeizel and Dudas,
1992). It has been estimated that the percentage of NTDs
that are folate sensitive globally is 75% (Bell and Oakley,
2009) and, for the United States, 50% (CDC, 1992).
The 1992 Centers for Disease Control and Prevention
recommendation of 400 lg daily folic acid supplement use
for women who could become pregnant, and the subse-
quent major public health campaign, were shown to result
in limited behavior change in the United States. This,
together with the fact that 50% of pregnancies in the
United States are unplanned, led to the fortification of sta-
ple foods with folic acid being mandated in January 1998.
Fortification was also mandatory less than a year later in
Canada (Dunlap et al., 2011). Data from the United States
that included prenatal diagnoses of NTDs found that post-
fortification there was a 27% decline in NTDs (CDC, 2004)
and for Canada, data similarly including prenatal NTD
diagnoses, found a 46% reduction (De Wals et al., 2007).
In 1992, the U.K. Department of Health issued a recom-
mendation that 400 lg of folic acid per day should be taken
during the periconceptional period: before conception and
throughout the first 12 weeks of pregnancy. This was
increased to 5 mg per day for women with a risk of folate
deficiency or previous NTD, and also for women with dia-
betes or epilepsy. An audit of women’s compliance with
this advice found that only 3% of women in the study sam-
ple had taken folic acid supplements in the preconception
period (Clark and Fisk, 1994). This resulted in a Health
Education Authority (HEA) Campaign being launched in
February 1996. Key components of this campaign were to
increase awareness of the importance of taking folic acid
periconceptionally, to educate health professionals and to
promote voluntary fortification (Raats et al., 1998). An audit
in 1996 to 1997 found that, although knowledge of the bene-
ficial effects of folic acid had increased, compliance was still
low (Neill et al., 1999). Despite these findings, a decision to
introduce mandatory folic acid food fortification was not
implemented in the U.K.
It is unclear whether NTD rates have declined in the
U.K. post-1992, when the folic acid supplementation pol-
icy was introduced. Botto et al. (2005) reported that sup-
plementation policies in several countries, including the
U.K., did not seem to have influenced trends in NTDs up
to 6 years after policy introduction. Busby et al. (2005)
found that NTD prevalence in the U.K. and Ireland had
fallen by 32%, but this continued a pre-existing downward
trend in NTD frequency. Although it is similarly difficult
to establish how much of the decline postfortification in
the United States and Canada is due to a pre-existing
reduction, the clear drop in NTD rates in both countries
was matched by an increase in average red blood cell
folate concentrations in the early years postfortification
(CDC, 2007), supportive of a causal link. There is still no
mandatory fortification policy in the U.K., or anywhere in
Europe, so improvement in periconceptional knowledge
and voluntary use of folic acid remains a high priority.
A recent systematic review reported that periconcep-
tional folic acid use remains low in the U.K., with 48% of
women taking folic acid periconceptionally as a best esti-
mate, and only 21% as the worst (Stockley and Lund,
2008). Unintended pregnancy, age, socioeconomic status,
and ethnic group were identified as important factors
associated with low folic acid supplement use. It is
argued that the factor most associated with low folic acid
supplement use is unintended pregnancy, followed by
age, socioeconomic status, and then ethnic group (Stock-
ley and Lund, 2008). However, while the majority of
U.K. studies have assessed folic acid knowledge and use
in the U.K. with reference to socioeconomic status and
age, very few have investigated the role of ethnicity.
The 2011 Office for National Statistics census data for
England and Wales showed that 86% of usual residents
are White (80% of total population were White British),
7.5% Asian/Asian British (2.5% Indian, 2% Pakistani, 1.5%
Other Asian, 0.8% Bangladeshi, and 0.7% Chinese), and
3.3% Black/African (1.8% African, 1.1% Caribbean, and
0.5% Other Black). In London, 18.5% of the population is
Asian/Asian British and 13.3% Black/African (ONS, 2012).
The Health Survey for England conducted in 2004 found
that obesity levels are higher in Pakistani, Black African,
and Black Caribbean groups (Gatineau and Mathrani,
2011); poor diet, particularly for South Asians, and lower
socioeconomic status, were indicated as possible reasons
for this (Gatineau and Mathrani, 2011). It has also been
shown that women with type 2 diabetes are more likely to
come from ethnic minority groups (Macintosh et al., 2006).
It is known that women who are obese or have diabetes
have an increased risk of having an NTD-affected preg-
nancy (Macintosh et al., 2006; Waller et al., 2007).
Pre-1991 data from the North West Thames region in
the U.K. (which includes parts of London) found that the
incidence of NTDs (terminations were not included) in
the Pakistani population in the U.K. was higher than in
the European population. It is difficult to tell whether
this was a true difference or due to the Pakistani popula-
tion having fewer terminations (Chitty and Winter, 1989).
Post-1992 data, in the “folic acid era,” suggested that the
rate of NTD-affected pregnancies (including termina-
tions) in the North West Thames region was higher in
women of Pakistani or Indian origin (Michie et al., 1998).
Preliminary data from the West Midlands congenital
anomaly register also indicated a higher rate of NTD-
affected pregnancies in Pakistani women (Tonks et al.,
1995). Red cell folate concentrations were also lower in
Indian and Pakistani women, but it is difficult to tell
whether this was due to genetic mutations in folate
metabolizing genes or due to a lower folic acid intake, or
a combination of the two (Michie et al., 1998).
A study conducted on much earlier data (1960–84),
before the folic acid era and during a period when very
few terminations would have been carried out, found
that the birth prevalence of spina bifida was significantly
higher in Europeans than those of South Asian origin
(Leck and Lancashire, 1995), indicating that lower folic
acid intake is likely to be a greater contributor to the
increased rate of NTD-affected pregnancies in Indian and
Pakistani women in more recent years; this, however,
would need to be substantiated with further research.
Approximately 40% of pregnancies are estimated to be
unplanned in the U.K. (Dex and Joshi, 2004); therefore,
women may have knowledge of the benefits of folic acid
but do not take it because they are not planning to
become pregnant. However, recent folic acid campaigns
FOLIC ACID FOR PREVENTION OF NEURAL TUBE DEFECTS 445
Birth Defects Research (Part A) 97:444–451 (2013)
in the U.K., such as “Go Folic” (SHINE, 2012) have changed
the focus from those planning pregnancy to those who
might become pregnant (including women using contra-
ception and actively trying not to get pregnant). Studies
assessing women’s knowledge of the role of folic acid in
NTD prevention, and their sources of information, are
important for understanding why women do or do not use
folic acid. Specifically for ethnic communities this is critical
for identifying where health education campaigns should
be targeted and/or why a fortification policy is so impor-
tant. The current review, therefore, sought to evaluate how
folic acid knowledge and periconceptional use for NTD
prevention varies by ethnicity in the U.K.
MATERIALS AND METHODS
Study Selection
Medline, Embase, Pubmed, and Cochrane databases
were searched by one reviewer as part of a wider litera-
ture review looking at NTDs in ethnic communities
(using keyword and MESH search terms: neural tube
defect* and ethnic*). Titles, abstracts, and full articles
where necessary were scrutinized to identify U.K. studies
that used post-1991 data: that is, following publication of
the Medical Research Council’s vitamin study (MRC
Vitamin Study Research Group, 1991). The full articles
for all U.K. studies were downloaded, and studies that
had assessed folic acid knowledge or periconceptional
use in women of non-White or non-Caucasian ethnicity
were included in the review, irrespective of study
design. Referenced articles from extracted publications
were also reviewed for any relevant studies.
Study Evaluation
Papers that assessed knowledge of folic acid were
evaluated for their quantification of how many women
within different ethnic groups understood the benefits of
folic acid, and their sources of information. Papers that
studied folic acid use were evaluated for quantitative
information on numbers of women in different ethnic
communities who took folic acid in the periconceptional
period, although some studies included data on precon-
ceptional folic acid use only. All findings were evaluated
in the context of individual studies’ strengths (e.g., large
sample size for non-Caucasian participants) and limita-
tions (e.g., possible responder bias).
Meta-analysis
Preconceptional folic acid use in Caucasians was com-
pared with non-Caucasians across all relevant studies
using a random effects model, chosen because of
expected between-study variation. Relevant studies were
those in which preconceptional folic acid use had been
quantified in different ethnic groups that could appropri-
ately be categorized as Caucasian and non-Caucasian.
The metan command was used in STATA (StataCorp,
College Station, TX) to run the meta-analysis, which
includes estimating a suitable summary statistic for each
study, and then giving a weighted average of that statis-
tic across studies. The results were summarized in a for-
est plot. The metan command also gives an estimate of
heterogeneity across studies. The metafunnel command,
which produces a graph with treatment effects from
individual studies plotted on the x axis against a mea-
sure of study size on the y axis, was also used to investi-
gate any publication or other bias in the meta-analysis.
RESULTS
From the wider literature review looking at NTDs in eth-
nic communities, the full articles for 49 papers were down-
loaded. Of these, five met the full inclusion criteria: an
assessment of folic acid knowledge or use in those of non-
White or non-Caucasian ethnicity using post-1991 U.K. data
(Fig. 1). Study summaries are shown in Table 1 and specifi-
cally the breakdown of the number and proportion of par-
ticipants in each study by ethnicity, is shown in Table 2.
The main reason for excluding papers was that they did
not consider folic acid knowledge or use in those of non-
White or non-Caucasian ethnicity. For example, in one of
the excluded studies (Tedstone et al., 2008), minority eth-
nic participants were included but there were no specific
results reported, broken down by ethnicity, of knowledge
of the link between spina bifida and folic acid intake.
Folic Acid Knowledge
Howell et al. (2001) reported ethnic differences in
knowledge of folic acid benefits. Only 35% of Banglade-
shi women had heard of the benefits of folic acid com-
pared with 84% of white women. In contrast, Krischer
(1997) reported that, in an inner-city general practitioner
(GP) practice with a multi ethnic population, there were
no key differences between ethnic groups in their
Figure 1. Flow diagram detailing process of selection of studies
for inclusion in systematic review and meta-analysis. NTD, neu-
ral tube defect; UK, U.K.
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knowledge of the link between folic acid and spina bifida.
However, Krischer’s study was underpowered: of the two
GP practices studied, only the inner city practice (105 par-
ticipants) was multi-ethnic. Hence, numbers of partici-
pants were very small when different ethnic groups were
compared. In Jessa and Hampshire’s (1999) study, none of
the Pakistani women interviewed were aware of the link
between folic acid and NTDs. The two remaining studies
(Brough et al., 2009; Lane, 2011) did not report folic acid
knowledge in participants with reference to ethnicity and
no discrepancies could be inferred due to the relationship
between knowledge and uptake. Interestingly, Brough
et al. (2009) reported that only 16% of study participants
stated they knew nothing about folic acid.
Folic Acid Use
Four of the five studies reported data on folic acid use,
with two (Howell et al., 2001; Brough et al., 2009) finding
discrepancies between ethnic groups. Brough et al (2009)
found ethnic differences in preconception use of folic acid:
uptake was highest in Caucasians (19%) followed by
Asians (12%), West Indians (8%), and Africans (5%). A fur-
ther 23% of Caucasians had started to take folic acid post-
conception but before neural tube closure (6 weeks gesta-
tion cut-off in this study). Hence, it was concluded that
42% of all Caucasians had started to take folic acid before
neural tube closure compared with 20% of African and
19% of West Indian and Asian mothers in the study.
Brough and colleagues (2009) drew attention to two limita-
tions of their study: it was not powered to investigate folic
acid use and women taking multivitamins were excluded.
The latter exclusion criterion could have biased the study
toward participants of lower socioeconomic status, and
potentially influenced the study’s ethnic make-up. In addi-
tion to discrepancies in folic acid usage between different
ethnic groups, the study also found that folic acid was
more likely to be used by mothers from a higher socioeco-
nomic group or with higher education levels.
Howell et al. (2001) used univariate analysis to look at
the relationship between ethnicity and folic acid intake,
and multivariate analysis to control for the woman’s age,
school leaving age, social class, parity, planned pregnancy,
and whether women had heard about folic acid benefits.
However, only a modest difference in outcome was found
using these two analytical methods: white women were
5.7 times more likely to take folic acid preconception than
Bangladeshi women in the univariate analysis, and 5.2
times more likely in the multivariate analysis.
In the qualitative study by Jessa and Hampshire (1999),
none of the 13 Pakistani women interviewed increased their
folic acid consumption in the periconceptional period.
The remaining study (Lane, 2011) found that marital
status, income, and education were the factors that most
influenced periconceptional folic acid use, but that eth-
nicity was not a significant factor. However, there were
very few participants in ethnic groups other than White
British, potentially weakening the argument that ethnic-
ity was unimportant.
Sources of Information on Folic Acid
The media (including magazines, newspapers, televi-
sion, and radio) and health professionals (e.g., GPs and
midwives) were the most commonly reported sources of
information on folic acid (Krischer, 1997; Lane, 2011).
British Pakistani women in Jessa and Hampshire’s (1999)
study displayed great trust and respect for their GP and,
although none of the women could recall their GP giving
them any advice about folic acid, said they would only
take folic acid supplements if their GP told them to.
However, Lane (2011) reported that 81% of women who
took folic acid because their GP or midwife advised
them to do so, did not start taking the supplements until
after they became pregnant.
Meta-analysis
Data on preconceptional (as opposed to periconcep-
tional) folic acid use in Caucasian and non-Caucasian
women were included in three of the five studies
(Howell et al., 2001; Brough et al., 2009; Lane, 2011), and
so we used this information in the meta-analysis. In con-
trast, only two studies assessed knowledge of the bene-
fits of folic acid, broken down by ethnicity, and it was
judged inappropriate to carry out a meta-analysis in this
case, owing to lack of data.
Caucasians were compared with non-Caucasians as
the contributing studies differed in their ethnic mix of
participants and one study did not break ethnicity down
any further than Caucasian British and Other (Lane,
2011). The meta-analysis across the three studies, using a
Table 2
Breakdown by Ethnicity of the Number and Proportion of Participants in Each Study
No. of cases (% of total in each study)
Ethnicity
Krischer,
1997
Jessa and
Hampshire, 1999
Howell et al.,
2001
Brough et al.,
2009 Lane, 2011
White or Caucasian White: 166 (80) White: 100 (40) Caucasian: 155 (39) White: 307 (80)
Afro-Caribbean 15 (7)
Asian 18 (9) 42 (10) 32 (8)
Pakistani 13 (100)
Bangladeshi 120 (48)
African 111 (28)
West Indian 66 (16)
Black 15 (4)
Chinese 2 (1)
Mixed race 5 (1)
Other/Unknown 9 (4) 29 (12) 28 (7) 25 (6)
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random effects model, shows that Caucasians are almost
three times as likely to take folic acid before conception
as non-Caucasians in the U.K. (95% confidence interval:
1.42, 5.44) (Fig. 2). A random effects model was appro-
priately chosen (between study variation is allowed) as
the analysis showed evidence of heterogeneity across
studies that was of borderline significance (p5 0.049).
Therefore, although Lane (2011) found no significant dif-
ference in preconceptional folic acid use between Cauca-
sians and non-Caucasians, when the results from the
three studies are pooled, there is a clear treatment effect.
Investigations for bias in the meta-analysis found that no
study unduly swayed the final treatment effect.
DISCUSSION
In this study, we aimed to evaluate how folic acid
knowledge and periconceptional usage for NTD preven-
tion varies by ethnicity in the U.K. Considering previously
published evidence, five studies met the inclusion criteria:
to have assessed folic acid knowledge and/or periconcep-
tional folic acid use in participants, including women of
non-Caucasian ethnicity. A synthesis of folic acid usage
data from three studies, in a meta-analysis, shows that
Caucasians are almost three times more likely to have
taken folic acid before conception than non-Caucasians.
This study has been checked against PRISMA guidelines
and meets accepted standards.
Studies were selected for our review by scrutiny of the
wider literature on NTDs in ethnic communities. The
aim was to ensure that all studies providing information
on folic acid knowledge or use in the periconceptional
period, in Caucasian and non-Caucasian communities,
were captured. Due to time constraints, only one
reviewer made determinations. However, the effective-
ness of our scrutiny method is indicated by the fact that
we identified all studies related to ethnicity included in
Stockley and Lund’s (2008) publication. This series of
systematic reviews concluded that ethnic group is one of
the factors associated with low use of folic acid
supplements.
Ethnicity was self-described in all studies included in
the meta-analysis, although both Brough et al. (2009) and
Lane (2011) combined ethnic groups for analytical pur-
poses. The study periods were diverse between the three
studies, which could have acted as a potential con-
founder. However, all were within the post-1991 “folic
acid era” and, because folic acid use has been consis-
tently low since folic acid supplementation policies were
implemented (Neill et al., 1999; Stockley and Lund,
2008), this argues that variations in the three study peri-
ods are unlikely to have markedly affected findings. All
studies included in the meta-analysis were conducted in
antenatal clinics, specifically during the first antenatal
visit for the Howell et al. (2001) and Brough et al. (2009)
studies, although this was not clearly stated in Lane’s
(2011) study. This is important as completing the ques-
tionnaire at the first antenatal visit, at the end of the
period when folic acid supplementation is recommended
(12 weeks), is likely to have resulted in clearer recall.
Studies included in the present review were conducted
in diverse areas throughout the U.K. Only Howell et al.
(2001) and Brough et al. (2009) included participants
from the same area: East London. Lane’s (2011) study
was conducted in South Wales where the ethnic make-
up is different. Combining these three studies in the
meta-analysis, therefore, could have introduced variation
due to geographical region within the U.K. that was
sampled.
Comparison in the meta-analysis was based on a broad
ethnic distinction: Caucasian versus non-Caucasian. This
is certainly a limitation of the data currently available, as
it does not allow conclusions to be drawn about specific
non-Caucasian groupings. It did, however, allow us to
focus specifically on whether U.K. Caucasian (i.e., largely
indigenous) women are more or less likely to take folic
acid preconceptionally than non-Caucasians (including
many migrant families).
There are indications that different non-Caucasian
groups may differ in their knowledge and use of folic
acid in the periconceptional period. Only two of the five
studies included in the review considered both knowl-
edge and use of folic acid in the periconceptional period,
broken down by ethnicity (Jessa and Hampshire, 1999;
Howell et al., 2001). Both studies reported low use of
folic acid that mirrored a lack of knowledge of folic acid
in women of South Asian origin. Brough et al. (2009)
found that preconceptional use of folic acid was even
lower in West Indians and Africans than Asians. How-
ever, no firm conclusions can be made on the basis of
the published data, owing to the small number of studies
and generally low participant numbers included.
The sources of information on folic acid that women
reported in the studies suggest some potentially impor-
tant conclusions. Jessa and Hampshire’s (1999) qualita-
tive study highlighted a clear lack of prepregnancy
advice on folic acid being given by the people the Paki-
stani women trusted most: their GPs. This is supported
by a study showing that, compared with non-Asians,
Asians are less concerned about the availability of over
the counter medicines, preferring to consult their GP to
obtain medication (Rashid et al., 1996). It would be
important to establish the effectiveness, therefore, of pro-
moting folic acid information in South Asian commun-
ities through South Asian media and community centers,
as recommended by Jessa and Hampshire (1999), given
Figure 2. Meta-analysis of preconceptional folic acid use in Cau-
casians compared with non-Caucasians. The odds ratio for each
individual study is given as well as an overall odds ratio across
the three studies. Weighting of each study was determined
according to the random effects model used for the meta-analysis.
FOLIC ACID FOR PREVENTION OF NEURAL TUBE DEFECTS 449
Birth Defects Research (Part A) 97:444–451 (2013)
that many women in this study said they would only
take folic acid supplements if their GPs advised them to.
Understanding why women do, or do not, take folic
acid in the periconceptional period is essential to inform
health education campaigns that are likely to have the
greatest impact. Indeed, this was a key aim of Lane’s
(2011) study, as a literature search had not identified any
British studies that specifically investigated this question.
While Lane’s findings were not broken down by ethnic-
ity, discovering pregnancy after 12 weeks of gestation
was the reason given most often (34%) for not taking
folic acid, presumably indicating the pregnancy was
unplanned.
Four of the five papers reviewed in the present study
(Krischer, 1997; Jessa and Hampshire, 1999; Brough et al.,
2009; Lane, 2011) argued for food fortification as the
most effective method of improving folate intake. Three
of these studies (Krischer, 1997; Jessa and Hampshire,
1999; Brough et al., 2009) argued that specifically ethnic
minority foods such as wheat and chapatti flour would
need to be fortified to ensure ethnic communities benefit
from fortification.
Research has been conducted in the United States to
assess the impact of fortification on different ethnic com-
munities. With respect to red blood cell folate levels,
non-Hispanic whites had the highest prefortification lev-
els followed by Hispanics, then non-Hispanic blacks. A
study comparing red blood cell folate levels before and
after fortification found that, despite absolute disparities
in red blood cell folate levels decreasing, relative differ-
ences actually increased between non-Hispanic whites
and non-Hispanic blacks, although there was no change
in the relative difference between non-Hispanic whites
and Hispanics (Dowd and Aiello, 2008). Twice as many
non-Hispanic whites (43.9%) take folic acid supplements
as Hispanics (20.8%) and non-Hispanic blacks (19.3%)
(Yang et al., 2007). For Hispanics, improved folic acid
supplement use needs to be promoted, in addition to for-
tification of corn flour, a staple constituent of the His-
panic diet that was not included in the mandatory fortifi-
cation policy in the United States, to improve folic acid
intake (Dunlap et al., 2011).
Conclusions
The results of the meta-analysis showed that Cauca-
sians are more likely to take folic acid preconception
than non-Caucasians. From the wider review, Asians,
specifically South Asian women, appear to have less
knowledge and lower usage of folic acid. However, fur-
thermore, more rigorous, research is required to make
any firm conclusions about diversity among non-
Caucasian population groups. An understanding of why
women do, or do not, take folic acid is critical for the
effective targeting of health education campaigns and
there is a clear need for more qualitative research in this
area. The qualitative study included in this review accen-
tuated the importance of GPs providing accurate pre-
pregnancy health information as part of routine practice,
as many appear to be giving advice to women about folic
acid when it is too late for their current pregnancy. Con-
clusions from the current study, together with other
important evidence from the U.K., United States, and
Canada, emphasize that carefully targeted, innovative
education campaigns to improve supplement use within
ethnic communities should be implemented in combina-
tion with a mandatory fortification policy, including the
fortification of ethnic minority foods, to ensure as many
NTDs are prevented as possible.
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